Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
14.50
-0.36 (-2.42%)
At close: Jul 18, 2025, 4:00 PM
14.26
-0.24 (-1.66%)
After-hours: Jul 18, 2025, 7:57 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $7.17 billion as of July 18, 2025. Its market cap has increased by 14,711.94% in one year.
Market Cap
7.17B
Enterprise Value
7.16B
1-Year Change
14,711.94%
Ranking
Category
Stock Price
$14.50
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $7.17B, an increase of 5,870.10%. That is a compound annual growth rate of 177.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 7.17B | 11,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.07B |
| Johnson & Johnson | 395.80B |
| AbbVie | 338.57B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 260.43B |
| Novartis AG | 224.54B |
| AstraZeneca | 214.46B |
| Abbott Laboratories | 214.00B |